AURA
AURA
NASDAQ · Biotechnology

Aura Biosciences Inc

$7.01
-0.10 (-1.41%)
As of Aug 8, 1:58 AM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +363.1% upside
Low Target $26.53
Average Target $32.46
High Target $55.40
Current Price $7.01
Current
$7.01
Target
$32.46
$26.53 $32.46 avg $55.40
Scenario Analysis
Bear Case
$26.53
278.5%
Low target
Base Case
$32.46
+363.1%
Avg target
Bull Case
$55.40
+690.3%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$9.54
-26.5% from high
52-Week Low
$4.73
+48.2% from low
Target vs 52W High
$32.46
+240.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 79% $257.58 +4.7%
AMGN
Amgen Inc
Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -90.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -44.4%
BIIB
Biogen Inc
Buy 44 64% $91.45 -56.0%